July 8, 2020 / 6:16 PM / a month ago

BRIEF-Viralclear Pharmaceuticals & Albany Molecular Research Undertake Research To Investigate Potential Of Merimepodib To Fight SARS-CoV-2

July 8 (Reuters) - Viralclear Pharmaceuticals:

* VIRALCLEAR PHARMACEUTICALS PARTNERS WITH ALBANY MOLECULAR RESEARCH INC. (AMRI) ON THE MANUFACTURE OF MERIMEPODIB ACTIVE PHARMACEUTICAL INGREDIENT IN DEVELOPMENT FOR THE POTENTIAL TREATMENT OF COVID-19 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below